Transaction in Own Shares • May 13, 2011
Transaction in Own Shares
Open in ViewerOpens in native device viewer
May 13, 2011
On February 11, 2011, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.
Under the program Novozymes will buy back B shares for an amount of up to DKK 400 million in the period from February 11, 2011, to December 31, 2011.
The following transactions have been made under the program:
| Number of shares |
Average purchase price |
Transaction value, DKK |
|
|---|---|---|---|
| Accumulated, last announcement |
161,468 | 128,529,750 | |
| May 06, 2011 | 0 | 0 | |
| May 09, 2011 | 0 | 0 | |
| May 10, 2011 | 8,769 | 882.04 | 7,734,609 |
| May 11, 2011 | 0 | 0 | |
| May 12, 2011 | 4,580 | 877.98 | 4,021,148 |
| Accumulated under the program |
174,817 | 140,285,507 |
Transactions related to Novozymes' incentive programs have resulted in a net sale by Novozymes of 47,411 B shares in the period from May 6 to May 12. The shares related to these transactions were not part of the Safe Harbour share buyback program.
With the transactions stated above, Novozymes owns a total of 1,885,354 treasury shares, corresponding to 2.9% of the share capital. The total amount of shares in the company is 65,000,000, including treasury shares.
René Tronborg (Europe) Tel. (direct): +45 4446 2274 Tel. (mobile): +45 3077 2274
Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501
Press and media: Investor relations:
Tobias Bjorklund Tel. (direct): +45 4446 8682 Tel. (mobile): +45 3077 8682
Martin Riise Nielsen Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738
Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
Company announcement no. 28, 2011 Page 1 of 1 Novozymes A/S Investor Relations Krogshoejvej 36 2880 Bagsvaerd Denmark
Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.